American College of Rheumatology, Nov. 6-11

The annual meeting of the American College of Rheumatology was held this year from Nov. 6 to 11 in Orlando, Florida, and attendees included rheumatology specialists, physicians, scientists, and other health professionals. […]

The annual meeting of the American College of Rheumatology was held this year from Nov. 6 to 11 in Orlando, Florida, and attendees included rheumatology specialists, physicians, scientists, and other health professionals. The conference featured presentations focusing on the latest advances in the diagnosis and treatment of arthritis as well as other rheumatic and musculoskeletal diseases.

ACR: Brepocitinib Yields Improvements in Cutaneous Sarcoidosis

TUESDAY, Nov. 17, 2026 (HealthDay News) — For patients with cutaneous sarcoidosis, brepocitinib is associated with dose-dependent and clinically meaningful improvements, according to a study published online Nov. 10 in JAMA Dermatology to coincide with the annual meeting of the American College of Rheumatology, held from Nov. 6 to 11 in Orlando, Florida.

Read Full Text

ACR: Bimekizumab Demonstrates Superior Results to Risankizumab in Psoriatic Arthritis

TUESDAY, Nov. 17, 2026 (HealthDay News) — For patients with psoriatic arthritis, bimekizumab appears to be superior to risankizumab in terms of ≥50 percent improvement in American College of Rheumatology response criteria at week 16, with the benefits sustained to week 24, according to a study presented at the annual meeting of the American College of Rheumatology, held from Nov. 6 to 11 in Orlando, Florida.

Read Full Text

ACR: CAR T-Cell Therapy Shows Promise for Patients With Lupus

MONDAY, Nov. 16, 2026 (HealthDay News) — For patients with systemic lupus erythematosus, chimeric antigen receptor T-cell therapy is associated with consistent reductions in disease activity, according to research presented at the annual meeting of the American College of Rheumatology, held from Nov. 6 to 11 in Orlando, Florida.

Read Full Text

ACR: Retatrutide Beneficial in Adults With Painful Knee OA, Obesity

THURSDAY, Nov. 12, 2026 (HealthDay News) — Retatrutide treatment results in significantly greater reductions in the Western Ontario and McMaster Universities Osteoarthritis Index pain score and in body weight compared with placebo among adults with painful knee osteoarthritis and obesity, according to a study published online Nov. 8 in the New England Journal of Medicine to coincide with the annual meeting of the American College of Rheumatology, held from Nov. 6 to 11 in Orlando, Florida.

Read Full Text

ACR: Sustained Clinical Responses Seen With Neuroimmune Modulation for RA

THURSDAY, Nov. 12, 2026 (HealthDay News) — Twenty-four-month data show sustained clinical responses for patients receiving neuroimmune modulation therapy for rheumatoid arthritis, according to a study presented at the annual meeting of the American College of Rheumatology, held from Nov. 6 to 11 in Orlando, Florida.

Read Full Text

Page 1 of 1
Top 15 Online Casinos in Österreich mit Echtgeld 2025
casino-admiral-legale-online-casino-fur-osterreichische-spieler-mit-echter-spielgarantie